Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): causes and treatment View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-11-15

AUTHORS

Lise Christensen, Vibeke Breiting, Jens Vuust, Estrid Hogdall

ABSTRACT

BackgroundPolyacrylamide hydrogel (Aquamid), an atoxic non-immunogenic gel of the non-resorbable type, has gained widespread popularity as an injectable filler for facial augmentation. However, adverse events (AEs) have occurred, the nature of which seems obscure because of negative findings on culture and a pattern of foreign-body response on microscopy.DesignThis is a prospective study of case reports provided by physicians injecting Aquamid during the period 21 May 2001 to 15 September 2003.MaterialsAmong 40,000 persons injected, 55 were reported to have experienced AEs. Information from questionnaires distributed along with the product and follow-up information from involved physicians was collected into a database.ResultsAEs occurring mainly in lips and nasolabial folds were reported in 55 patients, with 51 requiring treatment. The time from the last gel injection to the debut of the AE varied from 2 to 364 days, with a median of 12 days. Seventeen patients presented with different types of reaction to the injection, and the exact cause of the AE was established in another 19. A complete follow-up until full recovery was available in only 43 cases (84%). A broad-spectrum antibiotic in high dosage was effective for a short time. Steroids and non-steroidal anti-inflammatory drugs (NSAIDs) tended to aggravate symptoms and to prolong treatment time.ConclusionsAEs presenting clinically as nodules or swellings later than 1 week and less than 1 year after the injection of polyacrylamide hydrogel (Aquamid) should be treated immediately with a broad-spectrum antibiotic (quinolone) in high dosage. Steroids or NSAIDs are contraindicated. More... »

PAGES

464-471

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00238-005-0005-2

DOI

http://dx.doi.org/10.1007/s00238-005-0005-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039572640


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400, Copenhagen, Denmark", 
          "id": "http://www.grid.ac/institutes/grid.411702.1", 
          "name": [
            "Department of Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark", 
            "Department of Pathology, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Christensen", 
        "givenName": "Lise", 
        "id": "sg:person.07424553602.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07424553602.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Holte Clinic of Plastic Surgery, Holte, Denmark", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Holte Clinic of Plastic Surgery, Holte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Breiting", 
        "givenName": "Vibeke", 
        "id": "sg:person.01162112051.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162112051.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Biochemistry, Statens Serum Institute, Copenhagen, Denmark", 
          "id": "http://www.grid.ac/institutes/grid.6203.7", 
          "name": [
            "Department of Clinical Biochemistry, Statens Serum Institute, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vuust", 
        "givenName": "Jens", 
        "id": "sg:person.01254725002.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254725002.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Virus, Hormones and Cancer, Danish Cancer Society, Copenhagen, Denmark", 
          "id": "http://www.grid.ac/institutes/grid.417390.8", 
          "name": [
            "Department of Virus, Hormones and Cancer, Danish Cancer Society, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hogdall", 
        "givenName": "Estrid", 
        "id": "sg:person.013736114334.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013736114334.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s002669900032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034717431", 
          "https://doi.org/10.1007/s002669900032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002669900217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025462548", 
          "https://doi.org/10.1007/s002669900217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00266-003-3019-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009872387", 
          "https://doi.org/10.1007/s00266-003-3019-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00190068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049439698", 
          "https://doi.org/10.1007/bf00190068"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00450610", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028629788", 
          "https://doi.org/10.1007/bf00450610"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002660010131", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017183924", 
          "https://doi.org/10.1007/s002660010131"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-11-15", 
    "datePublishedReg": "2005-11-15", 
    "description": "BackgroundPolyacrylamide hydrogel (Aquamid), an atoxic non-immunogenic gel of the non-resorbable type, has gained widespread popularity as an injectable filler for facial augmentation. However, adverse events (AEs) have occurred, the nature of which seems obscure because of negative findings on culture and a pattern of foreign-body response on microscopy.DesignThis is a prospective study of case reports provided by physicians injecting Aquamid during the period 21 May 2001 to 15 September 2003.MaterialsAmong 40,000 persons injected, 55 were reported to have experienced AEs. Information from questionnaires distributed along with the product and follow-up information from involved physicians was collected into a database.ResultsAEs occurring mainly in lips and nasolabial folds were reported in 55 patients, with 51 requiring treatment. The time from the last gel injection to the debut of the AE varied from 2 to 364 days, with a median of 12 days. Seventeen patients presented with different types of reaction to the injection, and the exact cause of the AE was established in another 19. A complete follow-up until full recovery was available in only 43 cases (84%). A broad-spectrum antibiotic in high dosage was effective for a short time. Steroids and non-steroidal anti-inflammatory drugs (NSAIDs) tended to aggravate symptoms and to prolong treatment time.ConclusionsAEs presenting clinically as nodules or swellings later than 1 week and less than 1 year after the injection of polyacrylamide hydrogel (Aquamid) should be treated immediately with a broad-spectrum antibiotic (quinolone) in high dosage. Steroids or NSAIDs are contraindicated.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00238-005-0005-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1015056", 
        "issn": [
          "0930-343X", 
          "1435-0130"
        ], 
        "name": "European Journal of Plastic Surgery", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "keywords": [
      "non-steroidal anti-inflammatory drugs", 
      "broad-spectrum antibiotics", 
      "adverse events", 
      "high dosage", 
      "anti-inflammatory drugs", 
      "prospective study", 
      "case report", 
      "adverse reactions", 
      "foreign-body response", 
      "involved physicians", 
      "negative findings", 
      "full recovery", 
      "exact cause", 
      "gel injection", 
      "nasolabial folds", 
      "injection", 
      "facial augmentation", 
      "patients", 
      "steroids", 
      "physicians", 
      "antibiotics", 
      "injectable fillers", 
      "treatment", 
      "cause", 
      "dosage", 
      "days", 
      "treatment time", 
      "DesignThis", 
      "symptoms", 
      "weeks", 
      "median", 
      "drugs", 
      "Aquamid", 
      "questionnaire", 
      "lip", 
      "nodules", 
      "augmentation", 
      "report", 
      "swelling", 
      "widespread popularity", 
      "findings", 
      "debut", 
      "years", 
      "persons", 
      "response", 
      "time", 
      "short time", 
      "recovery", 
      "study", 
      "cases", 
      "types", 
      "database", 
      "events", 
      "culture", 
      "different types", 
      "patterns", 
      "information", 
      "folds", 
      "reaction", 
      "polyacrylamide hydrogels", 
      "gel", 
      "microscopy", 
      "popularity", 
      "products", 
      "nature", 
      "hydrogels", 
      "filler", 
      "BackgroundPolyacrylamide", 
      "non-immunogenic gel", 
      "non-resorbable type", 
      "last gel injection", 
      "permanent facial filler polyacrylamide hydrogel", 
      "facial filler polyacrylamide hydrogel", 
      "filler polyacrylamide hydrogel"
    ], 
    "name": "Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): causes and treatment", 
    "pagination": "464-471", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039572640"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00238-005-0005-2"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00238-005-0005-2", 
      "https://app.dimensions.ai/details/publication/pub.1039572640"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_409.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00238-005-0005-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00238-005-0005-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00238-005-0005-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00238-005-0005-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00238-005-0005-2'


 

This table displays all metadata directly associated to this object as RDF triples.

187 TRIPLES      22 PREDICATES      105 URIs      91 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00238-005-0005-2 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N6d97fbb2c92a423bb4e94d5db3c8f276
4 schema:citation sg:pub.10.1007/bf00190068
5 sg:pub.10.1007/bf00450610
6 sg:pub.10.1007/s00266-003-3019-9
7 sg:pub.10.1007/s002660010131
8 sg:pub.10.1007/s002669900032
9 sg:pub.10.1007/s002669900217
10 schema:datePublished 2005-11-15
11 schema:datePublishedReg 2005-11-15
12 schema:description BackgroundPolyacrylamide hydrogel (Aquamid), an atoxic non-immunogenic gel of the non-resorbable type, has gained widespread popularity as an injectable filler for facial augmentation. However, adverse events (AEs) have occurred, the nature of which seems obscure because of negative findings on culture and a pattern of foreign-body response on microscopy.DesignThis is a prospective study of case reports provided by physicians injecting Aquamid during the period 21 May 2001 to 15 September 2003.MaterialsAmong 40,000 persons injected, 55 were reported to have experienced AEs. Information from questionnaires distributed along with the product and follow-up information from involved physicians was collected into a database.ResultsAEs occurring mainly in lips and nasolabial folds were reported in 55 patients, with 51 requiring treatment. The time from the last gel injection to the debut of the AE varied from 2 to 364 days, with a median of 12 days. Seventeen patients presented with different types of reaction to the injection, and the exact cause of the AE was established in another 19. A complete follow-up until full recovery was available in only 43 cases (84%). A broad-spectrum antibiotic in high dosage was effective for a short time. Steroids and non-steroidal anti-inflammatory drugs (NSAIDs) tended to aggravate symptoms and to prolong treatment time.ConclusionsAEs presenting clinically as nodules or swellings later than 1 week and less than 1 year after the injection of polyacrylamide hydrogel (Aquamid) should be treated immediately with a broad-spectrum antibiotic (quinolone) in high dosage. Steroids or NSAIDs are contraindicated.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree false
16 schema:isPartOf N1bc0d25b5339409fad500792b6c4dfd8
17 N29816f587ec7450b9eca44ed8a9ef20f
18 sg:journal.1015056
19 schema:keywords Aquamid
20 BackgroundPolyacrylamide
21 DesignThis
22 adverse events
23 adverse reactions
24 anti-inflammatory drugs
25 antibiotics
26 augmentation
27 broad-spectrum antibiotics
28 case report
29 cases
30 cause
31 culture
32 database
33 days
34 debut
35 different types
36 dosage
37 drugs
38 events
39 exact cause
40 facial augmentation
41 facial filler polyacrylamide hydrogel
42 filler
43 filler polyacrylamide hydrogel
44 findings
45 folds
46 foreign-body response
47 full recovery
48 gel
49 gel injection
50 high dosage
51 hydrogels
52 information
53 injectable fillers
54 injection
55 involved physicians
56 last gel injection
57 lip
58 median
59 microscopy
60 nasolabial folds
61 nature
62 negative findings
63 nodules
64 non-immunogenic gel
65 non-resorbable type
66 non-steroidal anti-inflammatory drugs
67 patients
68 patterns
69 permanent facial filler polyacrylamide hydrogel
70 persons
71 physicians
72 polyacrylamide hydrogels
73 popularity
74 products
75 prospective study
76 questionnaire
77 reaction
78 recovery
79 report
80 response
81 short time
82 steroids
83 study
84 swelling
85 symptoms
86 time
87 treatment
88 treatment time
89 types
90 weeks
91 widespread popularity
92 years
93 schema:name Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): causes and treatment
94 schema:pagination 464-471
95 schema:productId N6199a0d1a6524d85bfc729127b177433
96 N9116a03eff474557ba292763e2533a8e
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039572640
98 https://doi.org/10.1007/s00238-005-0005-2
99 schema:sdDatePublished 2022-01-01T18:15
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher Na3bb5a658c304f578a32599483b6d504
102 schema:url https://doi.org/10.1007/s00238-005-0005-2
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N1bc0d25b5339409fad500792b6c4dfd8 schema:issueNumber 7
107 rdf:type schema:PublicationIssue
108 N29816f587ec7450b9eca44ed8a9ef20f schema:volumeNumber 28
109 rdf:type schema:PublicationVolume
110 N41cd661733cc4f59b7265b63c8c040df rdf:first sg:person.013736114334.16
111 rdf:rest rdf:nil
112 N6199a0d1a6524d85bfc729127b177433 schema:name dimensions_id
113 schema:value pub.1039572640
114 rdf:type schema:PropertyValue
115 N6d97fbb2c92a423bb4e94d5db3c8f276 rdf:first sg:person.07424553602.99
116 rdf:rest N9abc9c4bbcbc4f19ac54d84fcd3221af
117 N9116a03eff474557ba292763e2533a8e schema:name doi
118 schema:value 10.1007/s00238-005-0005-2
119 rdf:type schema:PropertyValue
120 N9abc9c4bbcbc4f19ac54d84fcd3221af rdf:first sg:person.01162112051.50
121 rdf:rest Na1e6e2a9d8514ad7a91fb6847c42b663
122 Na1e6e2a9d8514ad7a91fb6847c42b663 rdf:first sg:person.01254725002.59
123 rdf:rest N41cd661733cc4f59b7265b63c8c040df
124 Na3bb5a658c304f578a32599483b6d504 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
127 schema:name Medical and Health Sciences
128 rdf:type schema:DefinedTerm
129 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
130 schema:name Clinical Sciences
131 rdf:type schema:DefinedTerm
132 sg:journal.1015056 schema:issn 0930-343X
133 1435-0130
134 schema:name European Journal of Plastic Surgery
135 schema:publisher Springer Nature
136 rdf:type schema:Periodical
137 sg:person.01162112051.50 schema:affiliation grid-institutes:None
138 schema:familyName Breiting
139 schema:givenName Vibeke
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162112051.50
141 rdf:type schema:Person
142 sg:person.01254725002.59 schema:affiliation grid-institutes:grid.6203.7
143 schema:familyName Vuust
144 schema:givenName Jens
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254725002.59
146 rdf:type schema:Person
147 sg:person.013736114334.16 schema:affiliation grid-institutes:grid.417390.8
148 schema:familyName Hogdall
149 schema:givenName Estrid
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013736114334.16
151 rdf:type schema:Person
152 sg:person.07424553602.99 schema:affiliation grid-institutes:grid.411702.1
153 schema:familyName Christensen
154 schema:givenName Lise
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07424553602.99
156 rdf:type schema:Person
157 sg:pub.10.1007/bf00190068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049439698
158 https://doi.org/10.1007/bf00190068
159 rdf:type schema:CreativeWork
160 sg:pub.10.1007/bf00450610 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028629788
161 https://doi.org/10.1007/bf00450610
162 rdf:type schema:CreativeWork
163 sg:pub.10.1007/s00266-003-3019-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009872387
164 https://doi.org/10.1007/s00266-003-3019-9
165 rdf:type schema:CreativeWork
166 sg:pub.10.1007/s002660010131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017183924
167 https://doi.org/10.1007/s002660010131
168 rdf:type schema:CreativeWork
169 sg:pub.10.1007/s002669900032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034717431
170 https://doi.org/10.1007/s002669900032
171 rdf:type schema:CreativeWork
172 sg:pub.10.1007/s002669900217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025462548
173 https://doi.org/10.1007/s002669900217
174 rdf:type schema:CreativeWork
175 grid-institutes:None schema:alternateName Holte Clinic of Plastic Surgery, Holte, Denmark
176 schema:name Holte Clinic of Plastic Surgery, Holte, Denmark
177 rdf:type schema:Organization
178 grid-institutes:grid.411702.1 schema:alternateName Department of Pathology, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400, Copenhagen, Denmark
179 schema:name Department of Pathology, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400, Copenhagen, Denmark
180 Department of Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
181 rdf:type schema:Organization
182 grid-institutes:grid.417390.8 schema:alternateName Department of Virus, Hormones and Cancer, Danish Cancer Society, Copenhagen, Denmark
183 schema:name Department of Virus, Hormones and Cancer, Danish Cancer Society, Copenhagen, Denmark
184 rdf:type schema:Organization
185 grid-institutes:grid.6203.7 schema:alternateName Department of Clinical Biochemistry, Statens Serum Institute, Copenhagen, Denmark
186 schema:name Department of Clinical Biochemistry, Statens Serum Institute, Copenhagen, Denmark
187 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...